Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Endocrine 2CNS 2

Conditions

Neuroendocrine Tumors 32Gastro-enteropancreatic neuroendocrine tumor 6Carcinoid Tumor 4Adenoma, Islet Cell 3Serotonin Syndrome 2Parkinson Disease 2Neuroblastoma 2Neoplasms 2Congenital Hyperinsulinism 2Advanced Gastroenteropancreatic Neuroendocrine Tumor 2Thymus Neoplasms 1Pancreatic Neuroendocrine Tumors in MEN1 1Pancreatic Neuroendocrine Tumors (pNET) 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors in Lung 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1Lymphoma, Follicular 1Liposarcoma 1Lewy Body Disease 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Flushing 1Fibrosarcoma 1Disease 1Digestive Neuroendocrine Tumors 1Diarrhea 1Carcinoid Tumors, Intestinal 1

Interventions

fluorodopa F 18 2Furosemide 14-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Parkinson Disease × NET × Clear all
NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

University of Alberta

Phase 3 Recruiting
800 enrolled
CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

NCT03042416 2022-01-10

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

University of Alberta

Phase 3 Completed
400 enrolled
CNSEndocrineNET

Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡